03:04 PM EDT, 07/18/2024 (MT Newswires) -- Proton Capital Corp (PTN.V), in a trading halt for about a month, said Thursday it has closed its brokered public offering of common shares, issuing a total of more than 72.3 million shares at $0.40 each, for a total of $28.925 million. Proton added it intends to use the net proceeds from the Offering as disclosed in a Prospectus. And the corporation expects to resume trading of its common shares at market open on Monday, July 22, 2024.

Of note, Proton will also change its name to PharmaCorp Rx, effective July 22. It will commence trading under the new name on the TSXV with the new trading symbol PCRX at market open.